Insiders · AIM

Nancy Bryan

Director at AIM ImmunoTech Inc. (AIM) since March 2023

Nancy Bryan has filed 10 insider reports with the SEC since April 2023, as director at AIM ImmunoTech Inc. (AIM). Nancy Bryan made no open-market purchases or sales in the last 12 months. The latest filing, on March 18, 2025, reports grant or award at AIM ImmunoTech Inc. (AIM).

Filings
10
Companies
1
Bought on market
$15K
Sold on market
None

Companies where Nancy Bryan is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
AIM ImmunoTech Inc. logo
AIM
AIM ImmunoTech Inc.
Directorsince March 2023291,882$15K$0.39$0.1146-71%Mar 18, 2025

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Compare Nancy Bryan with

Other insiders at the same companies

Questions about Nancy Bryan

What is Nancy Bryan's role at AIM ImmunoTech Inc.?
Nancy Bryan reports to the SEC as director at AIM ImmunoTech Inc. (AIM), according to the latest filing on March 18, 2025.
How many shares does Nancy Bryan own?
After the latest filing that states it, Nancy Bryan directly owned 291,882 shares of AIM ImmunoTech Inc. (AIM). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Nancy Bryan bought or sold stock recently?
The most recent open-market purchase was on March 21, 2024: bought 38,462 shares of AIM ImmunoTech Inc. (AIM) for $15K at an average of $0.39.
How do I get alerts when Nancy Bryan files?
Follow Nancy Bryan on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Nancy Bryan (SEC CIK 0001492613). Totals count each trade once, skipping amendments whose original is on file, from Apr 12, 2023 on. View on SEC EDGAR · Get this as JSON